LAWSUITS NEWS & LEGAL INFORMATION
Concentrated Acetaminophen Drops Recalled by Brookstone Pharmaceuticals
Brookstone Pharmaceuticals, LLC, Alpharetta, GA has initiated a nationwide recall of all lots of Concentrated Acetaminophen Drops (NDC#42192-504-16) in 16 ounce (473 ml) bulk containers.
This 16oz container is comparable to the size generally used to package regular strength acetaminophen liquid preparations. This aspect of the product coupled with the absence of an integrated dosage delivery device is a contributing factor to possible dosing errors, especially inadvertent overdosing. Brookstone has distributed 344 bottles nationally and has donated 5301 bottles to charity for international distribution.
Over dosage of acetaminophen may result in liver toxicity, kidney damage, and blood disorders. The FDA is aware of several medication error reports that document life-threatening or fatal adverse events in children less than 3 years of age, due to confusion associated with the concentrated versus regular strength acetaminophen liquid. Also, in a recent FDA advisory panel, it was recommended that one of the 2 strengths of acetaminophen should be removed from the market due to possible confusion which could result in overdosing.
Brookstone's concentrated acetaminophen contains acetaminophen 80 mg/0.8 mL. Regular strength acetaminophen elixir contains 160 mg/5 ml. The firm is recalling its product to the consumer level as a cautionary measure to minimize any confusion and potential risk to patients from dosing errors.
JULY-15-09: Brookstone Pharmaceuticals Recalls Concentrated Acetaminophen Drops [FDA: BOOKSTONE PHARMACEUTICALS RECALLS ALL LOTS OF CONCENTRATED ACETAMINOPHEN DROPS]
Published on Jul-15-09
This 16oz container is comparable to the size generally used to package regular strength acetaminophen liquid preparations. This aspect of the product coupled with the absence of an integrated dosage delivery device is a contributing factor to possible dosing errors, especially inadvertent overdosing. Brookstone has distributed 344 bottles nationally and has donated 5301 bottles to charity for international distribution.
Over dosage of acetaminophen may result in liver toxicity, kidney damage, and blood disorders. The FDA is aware of several medication error reports that document life-threatening or fatal adverse events in children less than 3 years of age, due to confusion associated with the concentrated versus regular strength acetaminophen liquid. Also, in a recent FDA advisory panel, it was recommended that one of the 2 strengths of acetaminophen should be removed from the market due to possible confusion which could result in overdosing.
Brookstone's concentrated acetaminophen contains acetaminophen 80 mg/0.8 mL. Regular strength acetaminophen elixir contains 160 mg/5 ml. The firm is recalling its product to the consumer level as a cautionary measure to minimize any confusion and potential risk to patients from dosing errors.
JULY-15-09: Brookstone Pharmaceuticals Recalls Concentrated Acetaminophen Drops [FDA: BOOKSTONE PHARMACEUTICALS RECALLS ALL LOTS OF CONCENTRATED ACETAMINOPHEN DROPS]
Legal Help
If you or a loved one has suffered adverse health effects from consuming this product, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.Published on Jul-15-09
READ MORE Drugs/Medical Settlements and Legal News